SLC5A3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.672800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.678400E-01
Normal-vs-Stage2
3.263600E-01
Normal-vs-Stage3
9.641600E-01
Normal-vs-Stage4
3.133200E-01
Stage1-vs-Stage2
2.317800E-01
Stage1-vs-Stage3
2.430600E-01
Stage1-vs-Stage4
4.318600E-01
Stage2-vs-Stage3
2.422400E-01
Stage2-vs-Stage4
3.359000E-01
Stage3-vs-Stage4
2.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.814400E-01
Normal-vs-AfricanAmerican
2.746800E-01
Normal-vs-Asian
5.101400E-01
Caucasian-vs-AfricanAmerican
9.987800E-01
Caucasian-vs-Asian
5.344000E-01
AfricanAmerican-vs-Asian
6.068600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.686800E-01
Normal-vs-Female
3.780600E-01
Male-vs-Female
6.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.224800E-01
Normal-vs-Age(41-60Yrs)
2.358200E-01
Normal-vs-Age(61-80Yrs)
4.597000E-01
Normal-vs-Age(81-100Yrs)
4.370800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.901800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.348600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.983200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.598600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.030400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.778600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.291800E-01
Normal-vs-Daily Drinker
5.810000E-01
Normal-vs-Weekly Drinker
4.722200E-01
Normal-vs-Occasional Drinker
3.478600E-01
Normal-vs-Social Drinker
3.362800E-01
Non Drinker-vs-Daily Drinker
8.880800E-01
Non Drinker-vs-Weekly Drinker
9.938800E-01
Non Drinker-vs-Occasional Drinker
1.692820E-01
Non Drinker-vs-Social Drinker
3.246800E-01
Daily Drinker-vs-Weekly Drinker
9.175600E-01
Daily Drinker-vs-Occasional Drinker
2.422800E-01
Daily Drinker-vs-Social Drinker
4.839400E-01
Weekly Drinker-vs-Occasional Drinker
2.066800E-01
Weekly Drinker-vs-Social Drinker
3.969000E-01
Occasional Drinker-vs-Social Drinker
6.157400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.782000E-01
Normal-vs-Grade 2
1.764990E-01
Normal-vs-Grade 3
1.056370E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.209800E-02
Grade 1-vs-Grade 3
1.002180E-03
Grade 1-vs-Grade 4
3.782000E-01
Grade 2-vs-Grade 3
8.424000E-02
Grade 2-vs-Grade 4
1.764990E-01
Grade 3-vs-Grade 4
1.056370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.025800E-01
Normal-vs-NonDiabetic
4.267800E-01
Diabetic-vs-NonDiabetic
5.212400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.839600E-01
Normal-vs-NoPancreatitis
4.336600E-01
Pancreatitis-vs-NoPancreatitis
3.764000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.513200E-01
Normal-vs-N1
3.356400E-01
N0-vs-N1
4.143000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.088200E-01
Normal-vs-TP53-NonMutant
8.369600E-01
TP53-Mutant-vs-TP53-NonMutant
1.603630E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
